# Precision rehabilitation for swallowing dysfunction after radiotherapy in head and neck cancer: current evidence, key controversies, and future perspectives

**Authors:** Youwei Li, Hongyun Zheng, Suyan Bi, Rui Zhu, Bo Yuan, Zhonya Li, Tingting Zhao, Wei Zhang

PMC · DOI: 10.3389/fonc.2026.1732142 · Frontiers in Oncology · 2026-02-19

## TL;DR

This review discusses how to improve swallowing recovery after head and neck cancer radiotherapy through personalized rehabilitation strategies.

## Contribution

The paper proposes a framework for precision rehabilitation, emphasizing individualized approaches and technology integration.

## Key findings

- Swallowing exercises are effective, but optimal timing and type remain controversial.
- Patient adherence can be improved using behavioral techniques and technology.
- Pre-treatment frailty and lymphedema significantly affect rehabilitation outcomes.

## Abstract

Swallowing dysfunction (dysphagia) is a devastating and highly prevalent sequela following radiotherapy (RT) for head and neck cancer (HNC), severely impairing patients’ quality of life and nutritional status. While rehabilitation is the cornerstone of management, the translation of evidence into effective clinical practice is hampered by significant heterogeneity in interventions, conflicting outcomes, and poor adherence.

This narrative review critically synthesizes current evidence from systematic reviews, randomized controlled trials, and prospective cohort studies published between January 2015 and March 2025. A structured literature search was conducted in the PubMed, Web of science and Embase databases using combinations of keywords including “head and neck neoplasms,” “dysphagia,” “radiotherapy,” “rehabilitation,” “swallowing exercises,” “adherence,” “frailty,” and “precision medicine.” The selection focused on high-impact studies that addressed key challenges, controversies, and emerging paradigms in the field. It moves beyond a descriptive summary to evaluate the contradictions in the literature and propose a framework for precision rehabilitation.

The efficacy of swallowing exercises is well-documented, but critical controversies persist. These include the optimal timing (prophylactic vs. reactive), the superiority of specific exercise regimens, and the unpredictable impact of radiotherapy dose constraints on functional outcomes beyond traditional pharyngeal constrictors. A pivotal, yet often overlooked, factor is patient adherence, which is multifactorial and can be improved through behavioral change techniques and technology-assisted strategies (e.g., mHealth, wearable sensors). Furthermore, emerging evidence highlights the need to consider specific patient phenotypes, such as pre-treatment frailty and the presence of internal lymphedema, which significantly influence rehabilitation success. The integration of objective assessments (e.g., HRM, DIGEST) is crucial for quantifying dysfunction and tailoring interventions.

The field of dysphagia rehabilitation in HNC is evolving from a one-size- fits-all approach towards precision medicine. Future efforts must focus on developing personalized rehabilitation pathways based on individual risk stratification (e.g., frailty, dose to specific musculature), integrating technology for monitoring and motivation, and fostering interdisciplinary collaboration among oncologists, speech-language pathologists, and behavioral scientists to bridge the gap between research evidence and lasting functional recovery.

## Linked entities

- **Diseases:** head and neck cancer (MONDO:0005627)

## Full-text entities

- **Genes:** TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}
- **Diseases:** frailty (MESH:D000073496), nasopharyngeal carcinoma (MESH:D000077274), radiation (MESH:D011832), severely restricted mouth opening (MESH:D045169), biomechanical deficits (MESH:D009461), tongue pressure deficits (MESH:D014060), OPC (MESH:C564935), positive (MESH:D000377), chewing dysfunction (MESH:D006331), MD Anderson (MESH:C535460), xerostomia (MESH:D014987), dentition loss (MESH:C566644), mucositis (MESH:D052016), depressive symptoms (MESH:D003866), aspiration pneumonia (MESH:D011015), toxicities (MESH:D064420), Non-Oropharyngeal Cancers (MESH:D009959), osteoradionecrosis of the jaw (MESH:D010025), HNL (MESH:D006258), impaired hyoid bone (MESH:D001847), Trismus (MESH:D014313), Lymphedema (MESH:D008209), Cancer (MESH:D009369), soft palate (MESH:C562950), malnutrition (MESH:D044342), pharyngeal weakness (MESH:D010612), pain (MESH:D010146), inflammation (MESH:D007249), dental caries (MESH:D003731), Dysphagia (MESH:D003680), Edentulism (MESH:D007575), oral cavity, laryngeal, and hypopharyngeal cancers (MESH:D007012), Symptom (MESH:D012816), fibrosis (MESH:D005355), tooth loss (MESH:D016388)
- **Chemicals:** fluoride (MESH:D005459), proton (MESH:D011522), PEG (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12960172/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12960172/full.md

## References

74 references — full list in the complete paper: https://tomesphere.com/paper/PMC12960172/full.md

---
Source: https://tomesphere.com/paper/PMC12960172